Background pattern
SOLIFENACIN/TAMSULOSIN CINFAMED 6 mg/0.4 mg EXTENDED-RELEASE TABLETS

SOLIFENACIN/TAMSULOSIN CINFAMED 6 mg/0.4 mg EXTENDED-RELEASE TABLETS

Ask a doctor about a prescription for SOLIFENACIN/TAMSULOSIN CINFAMED 6 mg/0.4 mg EXTENDED-RELEASE TABLETS

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use SOLIFENACIN/TAMSULOSIN CINFAMED 6 mg/0.4 mg EXTENDED-RELEASE TABLETS

Introduction

Package Leaflet: Information for the User

solifenacin/tamsulosin cinfamed 6 mg/0.4 mg modified-release tablets EFG

solifenacin succinate/tamsulosin hydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What solifenacin/tamsulosin cinfamed is and what it is used for

2 What you need to know before you take solifenacin/tamsulosin cinfamed

  1. How to take solifenacin/tamsulosin cinfamed 4. Possible side effects
  2. Storage of solifenacin/tamsulosin cinfamed
  3. Contents of the pack and other information

1. What solifenacin/tamsulosin cinfamed is and what it is used for

Solifenacin/tamsulosin cinfamed is a combination of two different medicines called solifenacin and tamsulosin in one tablet. Solifenacin belongs to a group of medicines called anticholinergics and tamsulosin belongs to a group of medicines called alpha-blockers.

Solifenacin/tamsulosin cinfamed is used in men to treat both moderate to severe filling symptoms and emptying symptoms of the lower urinary tract caused by bladder problems and by an enlarged prostate (benign prostatic hyperplasia). Solifenacin/tamsulosin cinfamed is used when previous treatment with monotherapy for this condition did not sufficiently relieve the symptoms.

When the prostate gland enlarges, it can cause urinary problems (emptying symptoms) such as delayed urination (difficulty starting urination), reduced urine flow (weak stream), dripping, and a feeling of incomplete emptying of the bladder. At the same time, the bladder is also affected and contracts spontaneously at times when urination is not desired. This causes filling symptoms such as changes in bladder sensation, urgency (a strong and sudden desire to urinate without warning), and having to urinate more frequently.

Solifenacin reduces the involuntary contractions of the bladder and increases the amount of urine that your bladder can hold. Therefore, you can expect to wait longer before you have to go to the bathroom. Tamsulosin allows urine to pass more easily through the urethra and facilitates urination.

2. What you need to know before you take solifenacin/tamsulosin cinfamed

Do not takesolifenacin/tamsulosin cinfamedif:

  • you are allergic to solifenacin or tamsulosin or any of the other ingredients of this medicine (listed in section 6).
  • you are undergoing renal dialysis.
  • you have severe liver disease.
  • you have severe kidney disease AND you are being treated with medicines that may decrease the elimination of solifenacin/tamsulosin cinfamed from the body (e.g. ketoconazole, ritonavir, nelfinavir, itraconazole). Your doctor or pharmacist will inform you if this is the case.
  • you have moderate liver disease AND you are being treated with medicines that may decrease the elimination of solifenacin/tamsulosin cinfamed from the body (e.g. ketoconazole, ritonavir, nelfinavir, itraconazole). Your doctor or pharmacist will inform you if this is the case.
  • you have a severe stomach or intestinal disorder (including toxic megacolon, a complication associated with ulcerative colitis).
  • you have a muscle disorder called myasthenia gravis, which can cause extreme weakness of certain muscles.
  • you have increased pressure in the eyes (glaucoma), with gradual loss of vision.
  • you experience fainting due to a decrease in blood pressure when changing posture (when sitting or standing up); this is called orthostatic hypotension.

Tell your doctor if you think you have any of these conditions.

Warnings and precautions

Consult your doctor or pharmacist before taking solifenacin/tamsulosin cinfamed if:

  • you have difficulty urinating (urinary retention).
  • you have any obstruction of the digestive tract.
  • you have a risk of decreased activity of the digestive tract (stomach and intestinal movements). Your doctor will inform you if this is the case.
  • you have a tear in the diaphragm (hiatal hernia) or heartburn and/or you are taking medicines that may cause or worsen esophagitis.
  • you have a certain type of nerve disease (autonomic neuropathy).
  • you have severe kidney disease.
  • you have moderate liver disease.

Regular medical check-ups are necessary to monitor the development of the condition for which you are being treated.

Solifenacin/tamsulosin cinfamed may affect blood pressure, which can cause dizziness, drowsiness, or rarely, fainting (orthostatic hypotension). You should sit or lie down if you experience any of these symptoms until they have disappeared.

If you are going to have or have scheduled eye surgery due to cataracts or increased pressure in the eyes (glaucoma), please inform your ophthalmologist that you have previously used, are using, or plan to use solifenacin/tamsulosin cinfamed. The specialist can then take the necessary precautions regarding medication and surgical techniques to be used. Ask your doctor if you should postpone or temporarily interrupt taking this medicine when you are going to have eye surgery for cataracts or increased pressure in the eye (glaucoma).

Use in children and adolescents

Do not give this medicine to children and adolescents.

Other medicines and solifenacin/tamsulosin cinfamed

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

It is especially important that you inform your doctor if you are taking:

  • medicines such as ketoconazole, erythromycin, ritonavir, nelfinavir, itraconazole, verapamil, diltiazem, and paroxetine, which reduce the rate at which solifenacin/tamsulosin cinfamed is eliminated from the body.
  • other anticholinergic medicines, as the effects and side effects of both medicines may be intensified if you are taking two medicines of the same type.
  • cholinergic medicines, as they may reduce the effect of solifenacin/tamsulosin cinfamed.
  • medicines such as metoclopramide and cisapride, which may speed up the functioning of the digestive tract. Solifenacin/tamsulosin cinfamed may reduce their effect.
  • other alpha-blockers, as they may cause an undesired decrease in blood pressure.
  • medicines such as bisphosphonates, which may cause or exacerbate inflammation of the esophagus (esophagitis).

Solifenacin/tamsulosin cinfamed with food and drinks

Solifenacin/tamsulosin cinfamed can be taken with or without food, according to your preferences.

Pregnancy, breastfeeding, and fertility

Solifenacin/tamsulosin cinfamed is not indicated for use in women.

In men, abnormal ejaculation (ejaculation disorder) has been reported. This means that the semen is not released through the urethra, but instead goes into the bladder (retrograde ejaculation) or that the ejaculated volume is reduced or nonexistent (ejaculatory insufficiency). This phenomenon is harmless.

Driving and using machines

Solifenacin/tamsulosin cinfamed may cause dizziness, blurred vision, fatigue, and less frequently, drowsiness. If you experience these side effects, do not drive or use machines.

3. How to take solifenacin/tamsulosin cinfamed

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.

The maximum daily dose is one tablet containing 6 mg of solifenacin and 0.4 mg of tamsulosin, taken orally. It can be taken with or without food, depending on your preferences. Do not crush or chew the tablet.

If you take more solifenacin/tamsulosin cinfamed than you should

If you have taken more tablets than you were told to, or if someone else has taken your tablets by mistake, contact your doctor, pharmacist, or hospital immediately for advice.

In case of overdose, your doctor may treat you with activated charcoal; emergency stomach lavage may be useful if performed within one hour of overdose. Do not induce vomiting.

The symptoms of overdose may include: dry mouth, dizziness, and blurred vision, seeing things that are not there (hallucinations), over-excitability, convulsions, difficulty breathing, increased heart rate (tachycardia), inability to completely or partially empty the bladder or to urinate (urinary retention), and/or undesired increase in blood pressure.

In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take solifenacin/tamsulosin cinfamed

Take your next solifenacin/tamsulosin cinfamed tablet as normal. Do not take a double dose to make up for forgotten doses.

If you stop taking solifenacin/tamsulosin cinfamed

If you stop taking solifenacin/tamsulosin cinfamed, your initial symptoms may reappear or worsen. Always consult your doctor if you are considering stopping treatment.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, solifenacin/tamsulosin cinfamed can cause side effects, although not everybody gets them.

The most serious side effect that has been observed with a frequency of less than 1 in 100 men during treatment with solifenacin/tamsulosin in clinical studies is acute urinary retention, which is a sudden inability to urinate. If you think you may have this, go to your doctor immediately. You may need to stop taking solifenacin/tamsulosin cinfamed.

Solifenacin/tamsulosin cinfamed may cause allergic reactions:

  • A serious allergic reaction (anaphylactic reaction) may occur with an unknown frequency.
  • Uncommon signs of allergic reactions may include skin rash (which may be itchy) or hives (urticaria).
  • Rare symptoms include swelling of the face, lips, mouth, tongue, or throat, which can cause difficulty swallowing or breathing (angioedema). Angioedema has been reported rarely with tamsulosin and very rarely with solifenacin. In case of angioedema, treatment with solifenacin/tamsulosin cinfamed should be definitively and immediately discontinued.

If you experience an allergic reaction or a severe skin reaction (e.g. formation of blisters and peeling of the skin), you should inform your doctor immediately and stop using solifenacin/tamsulosin cinfamed. Treatment and/or measures should be applied.

Very common side effects (may affect up to 1 in 10 men)

  • Dry mouth

Common side effects (may affect up to 1 in 10 men)

  • Constipation
  • Indigestion (dyspepsia)
  • Dizziness
  • Blurred vision
  • Fatigue
  • Abnormal ejaculation (ejaculation disorder). This means that the semen is not released through the urethra, but instead goes into the bladder (retrograde ejaculation) or that the ejaculated volume is reduced or nonexistent (ejaculatory insufficiency). This phenomenon is harmless.
  • Feeling of nausea
  • Abdominal pain

Uncommon side effects (may affect up to 1 in 100 men)

  • Drowsiness
  • Itching (pruritus)
  • Urinary tract infection, bladder infection (cystitis)
  • Taste disorder (dysgeusia)
  • Dry eyes
  • Nasal dryness- Gastroesophageal reflux disease
  • Dry throat
  • Dry skin
  • Difficulty urinating
  • Fluid accumulation in the lower legs (edema)
  • Headache
  • Fast or irregular heartbeat (palpitations)
  • Feeling of dizziness or weakness, especially when standing up (orthostatic hypotension)
  • Nasal congestion (rhinitis)
  • Diarrhea
  • Vomiting
  • Fatigue (asthenia)

Rare side effects (may affect up to 1 in 1,000 men)

  • Accumulation of a large amount of hardened feces in the large intestine (fecal impaction), colon obstruction
  • Feeling of fainting (syncope)
  • Allergic reaction in the skin that causes swelling in the tissue under the skin surface (angioedema)

Very rare side effects (may affect up to 1 in 10,000 men)

  • Hallucinations, confusion
  • Allergic reaction in the skin (erythema multiforme)
  • Prolonged and painful erection (usually not during sexual activity) (priapism)
  • Skin rash, inflammation, and blistering of the skin and/or mucous membranes of the lips, eyes, mouth, nasal passages, or genitals (Stevens-Johnson syndrome)

Frequency not known (cannot be estimated from the available data)- Decreased appetite

  • High levels of potassium in the blood (hyperkalemia) that can cause abnormal heart rhythm - Increased pressure in the eyes (glaucoma)
  • Irregular or abnormal heartbeat (prolonged QT interval, Torsades de Pointes, atrial fibrillation, arrhythmia)- Rapid heart rate (tachycardia)
  • Breathing difficulties (dyspnea)
  • During eye surgery for cataracts or increased pressure in the eye (glaucoma), it is possible that the pupil (the black circle in the center of the eye) may not increase in size properly. Additionally, the iris (the colored part of the eye) may become flaccid during surgery.- Voice disorder
  • Liver disorder
  • Muscle weakness
  • Kidney disorder
  • Vision disorder- Nosebleed (epistaxis)
  • Delirium
  • Intestinal disorder (ileus)
  • Abdominal discomfort
  • Severe skin allergy that causes peeling of the skin (exfoliative dermatitis)

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of solifenacin/tamsulosin cinfamed

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton or blister after EXP. The expiry date is the last day of the month stated.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Container Content and Additional Information

Composition ofsolifenacin/tamsulosina cinfamed

  • The active ingredients are: solifenacin succinate and tamsulosin hydrochloride.

Each modified-release tablet contains 6 mg of solifenacin succinate, which corresponds to 4.5 mg of solifenacin and 0.4 mg of tamsulosin hydrochloride, which corresponds to 0.37 mg of tamsulosin.

  • The other components are microcrystalline cellulose; macrogol; anhydrous colloidal silica; magnesium stearate; calcium hydrogen phosphate; silicified microcrystalline cellulose (microcrystalline cellulose and anhydrous colloidal silica); low-substituted hydroxypropylcellulose; hypromellose; red iron oxide (E172).

Appearance ofthe productand container content

Solifenacina/tamsulosina cinfamed: the 6 mg/0.4 mg tablets are round (9 mm in diameter), biconvex, red, film-coated, engraved with «6 04» on one side.

PA/aluminum/PVC/aluminum blister pack in an outer box containing 10, 30, 60 or 100 tablets.

Only some pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta 31620 Huarte (Navarra) - Spain

Manufacturer Responsible

Adamed Pharma S.A.

ul. Marszalka Józefa Pilsudskiego 5

95-200 Pabianice

Poland

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Member State

Medicinal Product Name

Poland

Solifenacin succinate + Tamsulosin hydrochloride Adamed

Austria

Solifenacin/Tamsulosin Adamed 6 mg/0.4 mg Tabletten mit veränderter

Bulgaria

Urifenacin

Croatia

Tancer 6 mg/0.4 mg tablete s prilagodenim oslobadanjem

France

VECALMYS 6 mg/0.4 mg, comprimé à libération modifiée

Greece

VALIREM

Italy

Luracin

Romania

SOLIFENACIN/TAMSULOZIN ADAMED 6 mg/0.4 mg comprimate cu eliberare modificata

Spain

Solifenacina/tamsulosina cinfamed 6 mg/0.4 mg comprimidos de liberación modificada EFG

Date of the last revision of this leaflet:June 2022

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

You can access detailed and updated information about this medicinal product by scanning the QR code included in the leaflet and packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/88509/P_88509.html

QR code to: https://cima.aemps.es/cima/dochtml/p/88509/P_88509.html

About the medicine

How much does SOLIFENACIN/TAMSULOSIN CINFAMED 6 mg/0.4 mg EXTENDED-RELEASE TABLETS cost in Spain ( 2025)?

The average price of SOLIFENACIN/TAMSULOSIN CINFAMED 6 mg/0.4 mg EXTENDED-RELEASE TABLETS in October, 2025 is around 30.07 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.

Alternatives to SOLIFENACIN/TAMSULOSIN CINFAMED 6 mg/0.4 mg EXTENDED-RELEASE TABLETS in other countries

The best alternatives with the same active ingredient and therapeutic effect.

Alternative to SOLIFENACIN/TAMSULOSIN CINFAMED 6 mg/0.4 mg EXTENDED-RELEASE TABLETS in Poland

Dosage form: Tablets, 6 mg + 0.4 mg
Active substance: tamsulosin and solifenacin
Manufacturer: Adamed Pharma S.A.
Prescription required
Dosage form: Tablets, 6 mg + 0.4 mg
Active substance: tamsulosin and solifenacin
Manufacturer: Adamed Pharma S.A.
Prescription required
Dosage form: Tablets, 6 mg + 0.4 mg
Active substance: tamsulosin and solifenacin
Manufacturer: Adamed Pharma S.A.
Prescription required
Dosage form: Tablets, 6 mg + 0.4 mg
Active substance: tamsulosin and solifenacin
Manufacturer: Adamed Pharma S.A.
Prescription required
Dosage form: Tablets, 6 mg + 0.4 mg
Active substance: tamsulosin and solifenacin
Prescription required
Dosage form: Tablets, 6 mg + 0.4 mg
Active substance: tamsulosin and solifenacin
Prescription required

Alternative to SOLIFENACIN/TAMSULOSIN CINFAMED 6 mg/0.4 mg EXTENDED-RELEASE TABLETS in Ukraine

Dosage form: tablets, 6 mg/0.4 mg
Active substance: tamsulosin and solifenacin
Manufacturer: Sinton Hispania, S.L.
Prescription required
Dosage form: tablets, 6mg/0.4mg
Active substance: tamsulosin and solifenacin
Dosage form: tablets, 6mg/0.4mg
Active substance: tamsulosin and solifenacin
Manufacturer: Adamed Farma S.A.
Prescription required

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe